COGT - Cogent Biosciences to Host Investor Webcast on December 11 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American Society of Hematology (ASH) Annual Meeting | Benzinga
- Event to review initial clinical data from SUMMIT Part 1a in patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)
- Additional clinical data update from APEX Part 1 in patients with Advanced Systemic Mastocytosis (AdvSM) also to be reviewed
WALTHAM, Mass. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the details of its investor webcast being held Monday, December 11, 2023 at 8:00 a.m. ET (5:00 a.m. PT). The SUMMIT data are being presented in an oral presentation at the American Society of Hematology (ASH) Annual Meeting on December 9, 2023 at 1:30 p.m. ET (10:30 a.m. PT), and the APEX data are being presented in a poster session on ...